Literature DB >> 19524636

Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis.

Yang Sun1, Jingbo Pi, Xueqian Wang, Erik J Tokar, Jie Liu, Michael P Waalkes.   

Abstract

Inorganic arsenic is a known human skin carcinogen. Chronic arsenic exposure results in various human skin lesions, including hyperkeratosis and squamous cell carcinoma (SCC), both characterized by distorted cytokeratin (CK) production. Prior work shows the human skin keratinocyte HaCaT cell line, when exposed chronically for >25 weeks to a low level of inorganic arsenite (100nM) results in cells able to produce aggressive SCC upon inoculation into nude mice. In the present study, CK expression analysis was performed in arsenic-exposed HaCaT cells during the progressive acquisition of this malignant phenotype (0-20 weeks) to further validate this model as relevant to epidermal carcinogenesis induced by arsenic in humans. Indeed, we observed clear evidence of acquired cancer phenotype by 20 weeks of arsenite exposure including the formation of giant cells, a >4-fold increase in colony formation in soft agar and a approximately 2.5-fold increase in matrix metalloproteinase-9 secretion, an enzyme often secreted by cancer cells to help invade through the local extra-cellular matrix. During this acquired malignant phenotype, various CK genes showed markedly altered expression at the transcript and protein levels in a time-dependent manner. For example, CK1, a marker of hyperkeratosis, increased up to 34-fold during arsenic-induced transformation, while CK13, a marker for dermal cancer progression, increased up to 45-fold. The stem cell marker, CK15, increased up to 7-fold, particularly during the later stages of arsenic exposure, indicating a potential emergence of cancer stem-like cells with arsenic-induced acquired malignant phenotype. The expression of involucrin and loricrin, markers for keratinocyte differentiation, increased up to 9-fold. Thus, during arsenic-induced acquired cancer phenotype in human keratinocytes, dramatic and dynamic alterations in CK expression occur which are consistent with the process of epidermal carcinogenesis helping validate this as an appropriate model for the study of arsenic-induced skin cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524636      PMCID: PMC2747077          DOI: 10.1016/j.tox.2009.06.003

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  46 in total

Review 1.  The keratins and their disorders.

Authors:  Elizabeth L Rugg; Irene M Leigh
Journal:  Am J Med Genet C Semin Med Genet       Date:  2004-11-15       Impact factor: 3.908

2.  Blackfoot disease.

Authors:  C J Chen
Journal:  Lancet       Date:  1990-08-18       Impact factor: 79.321

3.  Changes in keratinocyte maturation during wound healing.

Authors:  J N Mansbridge; A M Knapp
Journal:  J Invest Dermatol       Date:  1987-09       Impact factor: 8.551

4.  Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan.

Authors:  W P Tseng; H M Chu; S W How; J M Fong; C S Lin; S Yeh
Journal:  J Natl Cancer Inst       Date:  1968-03       Impact factor: 13.506

5.  Intermediate filaments: cell-type-specific markers in differentiation and pathology.

Authors:  M Osborn; K Weber
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

6.  Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid.

Authors:  D Hohl; U Lichti; D Breitkreutz; P M Steinert; D R Roop
Journal:  J Invest Dermatol       Date:  1991-04       Impact factor: 8.551

7.  Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia.

Authors:  A C Markey; E B Lane; L J Churchill; D M MacDonald; I M Leigh
Journal:  J Invest Dermatol       Date:  1991-11       Impact factor: 8.551

Review 8.  Arsenic-induced skin toxicity.

Authors:  R L Shannon; D S Strayer
Journal:  Hum Toxicol       Date:  1989-03

9.  Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes.

Authors:  R A Weiss; R Eichner; T T Sun
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

10.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.

Authors:  P Boukamp; R T Petrussevska; D Breitkreutz; J Hornung; A Markham; N E Fusenig
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  17 in total

Review 1.  State of the science review of the health effects of inorganic arsenic: Perspectives for future research.

Authors:  Paul B Tchounwou; Clement G Yedjou; Udensi K Udensi; Maricica Pacurari; Jacqueline J Stevens; Anita K Patlolla; Felicite Noubissi; Sanjay Kumar
Journal:  Environ Toxicol       Date:  2018-12-04       Impact factor: 4.119

2.  Differentially Expressed mRNA Targets of Differentially Expressed miRNAs Predict Changes in the TP53 Axis and Carcinogenesis-Related Pathways in Human Keratinocytes Chronically Exposed to Arsenic.

Authors:  Laila Al-Eryani; Sabine Waigel; Ashish Tyagi; Jana Peremarti; Samantha F Jenkins; Chendil Damodaran; J C States
Journal:  Toxicol Sci       Date:  2018-04-01       Impact factor: 4.849

3.  Low-level arsenic causes proteotoxic stress and not oxidative stress.

Authors:  Matthew Dodson; Montserrat Rojo de la Vega; Bryan Harder; Raul Castro-Portuguez; Silvia D Rodrigues; Pak Kin Wong; Eli Chapman; Donna D Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2018-02-03       Impact factor: 4.219

4.  Overabundance of putative cancer stem cells in human skin keratinocyte cells malignantly transformed by arsenic.

Authors:  Yang Sun; Erik J Tokar; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2011-10-19       Impact factor: 4.849

5.  Arsenic transformation predisposes human skin keratinocytes to UV-induced DNA damage yet enhances their survival apparently by diminishing oxidant response.

Authors:  Yang Sun; Chikara Kojima; Colin Chignell; Ronald Mason; Michael P Waalkes
Journal:  Toxicol Appl Pharmacol       Date:  2011-07-21       Impact factor: 4.219

6.  Cell cycle pathway dysregulation in human keratinocytes during chronic exposure to low arsenite.

Authors:  Laila Al-Eryani; Sabine Waigel; Venkatakrishna Jala; Samantha F Jenkins; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-14       Impact factor: 4.219

7.  Arsenic-exposed Keratinocytes Exhibit Differential microRNAs Expression Profile; Potential Implication of miR-21, miR-200a and miR-141 in Melanoma Pathway.

Authors:  Horacio Gonzalez; Carolina Lema; Robert A Kirken; Rosa A Maldonado; Armando Varela-Ramirez; Renato J Aguilera
Journal:  Clin Cancer Drugs       Date:  2015

8.  Delineating the Effects of Passaging and Exposure in a Longitudinal Study of Arsenic-Induced Squamous Cell Carcinoma in a HaCaT Cell Line Model.

Authors:  Mayukh Banerjee; Laila Al-Eryani; Sudhir Srivastava; Shesh N Rai; Jianmin Pan; Theodore S Kalbfleisch; J Christopher States
Journal:  Toxicol Sci       Date:  2022-01-24       Impact factor: 4.849

9.  Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure.

Authors:  Elena V Komissarova; Toby G Rossman
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-28       Impact factor: 4.219

Review 10.  Arsenic-induced changes in miRNA expression in cancer and other diseases.

Authors:  Ana P Ferragut Cardoso; Karen T Udoh; J Christopher States
Journal:  Toxicol Appl Pharmacol       Date:  2020-10-28       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.